Amicus Therapeutics Aktie
6,90
EUR
-0,15
EUR
-2,13
%
8,35
USD
-0,14
USD
-1,65
%
Werbung
Amicus Therapeutics Aktie Analyse
17.06.19 | Amicus Therapeutics Buy | H.C. Wainwright & Co. | |
05.06.19 | Amicus Therapeutics Overweight | Cantor Fitzgerald | |
30.01.19 | Amicus Therapeutics Overweight | Cantor Fitzgerald | |
13.09.17 | Amicus Therapeutics Buy | Chardan Capital Markets | |
10.08.17 | Amicus Therapeutics Buy | Chardan Capital Markets | |
24.01.17 | Amicus Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
12.04.16 | Amicus Therapeutics Buy | Chardan Capital Markets | |
16.06.15 | Amicus Therapeutics Buy | Chardan Capital Markets | |
Werbung
|
|||
29.05.15 | Amicus Therapeutics Buy | Chardan Capital Markets | |
12.02.08 | Amicus Therapeutics | Global Insider Investing |
Werbung
Werbung